Autoimmune & Connective Tissue
Dental Management of Patients with Behçet's disease
Important — second opinion only. DentiCision provides an evidence-based second opinion to assist the dentist. It does not replace the treating dentist's professional clinical judgment or consultation with the patient's physician. The treating dentist retains full clinical, scientific and legal responsibility. Always verify drugs and doses against current guidelines.
Behçet's disease — confirm current activity
Behçet's causes recurrent oral (and genital) ulceration that can be triggered by mucosal trauma (pathergy). Patients often take colchicine, corticosteroids, azathioprine or anti-TNF agents, and vascular Behçet's may require anticoagulation.
Emergency vs routine management
If EMERGENCY — what to do
- • Treat pain/infection now with the gentlest technique — emergency care is never delayed.
If ROUTINE — what to do
- • Confirm disease activity to see the routine-care plan.
Clinical precautions
- • No routine antibiotic prophylaxis — consider only if neutropenic (ANC <1.0) or as advised by the treating physician; if indicated: amoxicillin 2 g 30–60 min pre-op (azithromycin 500 mg or doxycycline 100 mg if penicillin-allergic)
- • Minimise mucosal trauma: lubricate lips, gentle retraction, careful suction and impression technique
- • Ulcer control: topical corticosteroid (e.g. triamcinolone 0.1% in orabase / betamethasone mouthwash) ± chlorhexidine or benzydamine mouthwash
- • Also add the patient's medications (colchicine, steroids, azathioprine, anti-TNF, anticoagulant) — interaction, infection, stress-dose and bleeding checks are applied automatically
- • Undiagnosed recurrent oral ulcers with genital ulcers, eye or skin signs → refer to rheumatology
Information & tests to request
- • Is Behçet's disease currently active in the mouth? — Elective treatment is deferred during an active flare because trauma worsens lesions; quiescent disease is treated with precautions.
- • Daily prednisolone-equivalent dose (mg) — This patient's condition/therapy is commonly associated with long-term corticosteroids, which can suppress the adrenal response to surgical stress. Enter the daily dose (0 if none) to determine whether supplementary stress-dose cover is needed.
At a glance by procedure
Initial assessment before lab results or timing details are entered.
| Procedure | Initial assessment |
|---|---|
| Examination / radiographs | MODIFY / CAUTION Behçet's disease — confirm current activity |
| Supragingival scaling / polish | MODIFY / CAUTION Behçet's disease — confirm current activity |
| Deep scaling / subgingival RSD (subgingival calculus) | MODIFY / CAUTION Behçet's disease — confirm current activity |
| Root canal treatment | MODIFY / CAUTION Behçet's disease — confirm current activity |
| Simple extraction (1–3 teeth) | MODIFY / CAUTION Behçet's disease — confirm current activity |
| Surgical / bony extraction | MODIFY / CAUTION Behçet's disease — confirm current activity |
| Implant placement | MODIFY / CAUTION Behçet's disease — confirm current activity |
References
- Hatemi G et al. 2018 update of the EULAR recommendations for the management of Behçet's syndrome. Ann Rheum Dis 2018;77:808–818 (topical corticosteroids first-line for oral ulcers; colchicine to prevent recurrent mucocutaneous lesions)
- Behçet's UK — Behçet's mouth ulcers: patient & clinician guidance (topical steroids, chlorhexidine, SLS-free toothpaste)
- Pathergy: surgical/needle trauma can trigger new ulcers — Behçet's syndrome review, J Dermatol 2020 (doi:10.1111/1346-8138.15207)
- ADA — Antibiotic prophylaxis prior to dental procedures (no routine prophylaxis for immunocompromise alone)
Related guides
Important — second opinion only. DentiCision provides an evidence-based second opinion to assist the dentist. It does not replace the treating dentist's professional clinical judgment or consultation with the patient's physician. The treating dentist retains full clinical, scientific and legal responsibility. Always verify drugs and doses against current guidelines.